{"name":"Sorrento Therapeutics, Inc.","slug":"sorrento-therapeutics-inc","ticker":"","exchange":"","domain":"sorrentotherapeutics.com","description":"","hq":"San Diego","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Zilretta","genericName":"Zilretta","slug":"zilretta","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Zilretta","genericName":"Zilretta","slug":"zilretta","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9LNXNoUzRvQ2lnVVNzcTFIcHlkeHpXbGpZandrSW5UODhjb0ZjS0lLSVVXOUJ4OGJWT2ZleEtacTF2YUFTcDFnR0dYUXVaNVNxVERaNHliMWEtMnBKbVFJU29uOHB3OG5IVTNvTmFjQjl1WXZvN1h0c2FpUHl5QUk?oc=5","date":"2025-09-23","type":"pipeline","source":"Global Growth Insights","summary":"Who Are the Global Leaders in CAR T-Cell Therapy? Top 10 Companies List - Global Growth Insights","headline":"Who Are the Global Leaders in CAR T-Cell Therapy? Top 10 Companies List","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-07","type":"pipeline","source":"fox5sandiego.com","summary":"Ex-San Diego biotech company VP admits to illegally selling $1.3M worth of shares - fox5sandiego.com","headline":"Ex-San Diego biotech company VP admits to illegally selling $1.3M worth of shares - fox5sandiego.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQd3pnWXp1ZHZMczJxVFQ3Xy1ZU2hIVUdiVEhneVVXLXJ0M2RPMFN1aEE1QjhtcWNVTWVsU3VDTE1GY19UTlNvMk1kRE5hZHB2Vk1PbnhkY3ZtMndmUHJMcmlXenFFM2lpSzhBUGdLVndJR0I0d1pLaW56VXpDdmMyTW8xcmM3S1JzX0R2dVotZldVdnhtVU9rLWlNaDFvRXVBSnJ3SjdQblEwWnhTdWRveG1qc3dfdzZaVklINmo0Rm1NV1hoNUgxMzRraXFsNUQwOXlR?oc=5","date":"2024-09-03","type":"pipeline","source":"WSJ","summary":"Sorrento Therapeutics Restructuring Chief Hosted Party for Judges Who Later Oversaw Its Liquidation - WSJ","headline":"Sorrento Therapeutics Restructuring Chief Hosted Party for Judges Who Later Oversaw Its Liquidation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOM3o2V01DZ0dzLS1ucDdBVFlnM3NjY2d2RjN5OTYtT01hRU9uanRqRmxRdlktb1JoN0FqWG91OC1zUTZxWVJ5a2g1U3hmaU93OHotR2c3NjVSZUQxbUs5MGVNSDFKaVZrNzdkYk5ORFpoMnFER202ZGNJNnh0ZF9wZ1FyUFRjY1BpeG1MTG9RbHdXSDVDbm80dkpOSUU5M3ZJVXcwQ3VidmpLS2tTMFBhMnpKQ2NMQ1pFY2RwNmNWdw?oc=5","date":"2023-12-22","type":"pipeline","source":"Skadden, Arps, Slate, Meagher & Flom LLP","summary":"Court of Chancery Finds Officer Liable for Competing With Corporation and Misappropriating Trade Secrets - Skadden, Arps, Slate, Meagher & Flom LLP","headline":"Court of Chancery Finds Officer Liable for Competing With Corporation and Misappropriating Trade Secrets - Skadden, Arps","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQak9YcnhOcEJvMlFMRk1nUnMtTkhZV25rdVIycU1WV1FxRWtrXzJDeVdNYlVOZUF1T1FCUXl6c0g0WG42VXY5VjVpRXl1VFIyUGxDT3NydnhCbi1Ic21OTWRyb0YzVmVNcmxiRjZKWXNYZzh0Zm0tZEwzX1J3dnpxeUtfcjNGMjYzTUdGN0Z1QUdOLV9BeEE?oc=5","date":"2023-08-09","type":"pipeline","source":"Pharmaceutical Technology","summary":"Sorrento plans stock sale to raise $105m to recover from bankruptcy - Pharmaceutical Technology","headline":"Sorrento plans stock sale to raise $105m to recover from bankruptcy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQWkJreXBzZUtsWVBaMGxVZTB6X1ZmZ3JBMFJtdjJSQW1COXJvSXpuMjJaeWRYeG9hVlgzSTVNeldtS3piSUlEbVlJQVhkcTgtQlpmRGI1RzIyZjBDcWFTUTZaUzl4NDVSN1Vwd2plcTloaDlxaHB1QXFPenBQR1V6R0p4SGZyaV9jN0FYQU9lY1pJcjJEZ3JLcmJNSi1ReHZNTXc2Q3AyX2p6cjVH?oc=5","date":"2023-02-13","type":"deal","source":"Fierce Biotech","summary":"3 years after rejecting $1B buyout, Sorrento files for bankruptcy amid legal battles - Fierce Biotech","headline":"3 years after rejecting $1B buyout, Sorrento files for bankruptcy amid legal battles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQaTRkR0tnSUgzUmJpaU5hWGsxOGFEMUNpVF9sOEhmTktNWkpGSEhLeTN5cWVIUTVIMVRCV1JDQjBVVU9Xb21HamR3UnNXT3ZodVJtT0toM3lYcTBFRERTbFZ4eEpSQ0dFZVZqTWNjT0VIZFNyeFVjOTlqelJlQzJmclhzR0w1aEI0VTZxMlJ6d0Rvd255NDVLZExoYXdhWHBlWTd1N2l3REVJUEVUTF9fdTBxM1RrMHdJQkVaRlNiU1RNYVl4ZGN1RF9CcFpDcXVyTmZqeWdXMnRpdDZ1ZVoxSUNGcw?oc=5","date":"2023-02-13","type":"pipeline","source":"proactiveinvestors.com","summary":"Sorrento Therapeutics stock plummets more than 60% on news of bankruptcy filing - proactiveinvestors.com","headline":"Sorrento Therapeutics stock plummets more than 60% on news of bankruptcy filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPLUx4N2ZxRkxZQkJIaXZ1LU1aODZnanZiZmRkQzNadERXUUlCYjBPSjlQdlFweTI2Sm5FSVN4NGJWY1B2OG1vWGhnNzFIbi1LUDJpYU1NYUlhVmpFN3ZlUTRYRHRzSDdGN2RFTW5NUGpsOE1zQ2p1d19OYUlWbzg3aVVfbVpBZmo4UXEtR1ZKWUdtOUFoN3lUWDVhelhCOGMycERvd3JpZGRvdjJKdElBOGEzMnh6VVRhZWRwdkJqT0RnRURRajRNUDViVm9lR0xoczd3SjJMcDU?oc=5","date":"2021-09-29","type":"deal","source":"businesswire.com","summary":"ANP Technologies, Inc. Terminates Merger Negotiations with Sorrento Therapeutics, Inc. - businesswire.com","headline":"ANP Technologies, Inc. Terminates Merger Negotiations with Sorrento Therapeutics, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOX1RRcXBGU1VuMC16WUNIN1lqdHNSdVNKb0p6Q0RaOEhGck1QNXFUY3RQYTB1NmF0Nmk4V2Z0QTN3OXdhZEdNUHdvRFRqWXZJTW9kRkRyMmREUURjeWVtMVl0V0tGRUE1aDJkM2dlSmFWV3B2YzVGWTBDV3NVOFhHeDBXRkFqSW80MjZyZVE1SHRucU92ZnhtSV9jVkVYSkhZY3pqWGpZaHFDaG9CZHZFVGcyQk50ekVLdm5jN3lUX0wwMk9HUTZaMUV1SjByY0JTeDJEYkNibG9ZSDZRbmdxR0JreGRZMmdweFFYWl9EYWk?oc=5","date":"2021-06-02","type":"pipeline","source":"GlobeNewswire","summary":"Sorrento Completes Acquisition of ACEA Therapeutics, Creating a Major Oncology Franchise - GlobeNewswire","headline":"Sorrento Completes Acquisition of ACEA Therapeutics, Creating a Major Oncology Franchise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE54T3hMTC1QY1c2OXN0Vk1OMUxvMkpCTy1xNk9mWE1xSTVxd1pOQU5pRkdickJpVzU5VGp5MG1xSXYxZk1qRXVJMEZURzIzWVdOQXM2WFlHUHhUOUFlTTg0?oc=5","date":"2020-09-01","type":"pipeline","source":"nature.com","summary":"Novel immunotherapies to combine with PD-1/PD-L1 treatment - nature.com","headline":"Novel immunotherapies to combine with PD-1/PD-L1 treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOaVRsWGlueWZiVWlkWVl5TUVWbFliMi1yM0lQQXhHejZJM2ZFak90MnVYQm5pREFiNWF3Z3oyZHpGZHc5T3UwWlNmYXoteXlXQkFJOXNEcWZXMnh0UXNTaXBBNVJKSXlfX21DeklWN05hdVlyN2FqNldSc3dvRmJzOUIxYklBZXBfbWJSVVRvM1RVUDFVajY1X2lEYzFvYkJSaWxxODNsR0dxYzN0V0tTSXoyS1FCV1JpalhGQ2dMT1drTHRtOTlzYkFjczBuUGNhT0IxU0JHdHc2MTZ0MXdmVWgzVVN6MWdaMUxpWUJtUl95WVhtMmxDUjN0N3dVMVU2RjVIb2FIUjZ0Rkc0TWpTVlpTMmM?oc=5","date":"2017-11-14","type":"pipeline","source":"PR Newswire","summary":"Scilex Pharmaceuticals, Sorrento Therapeutics' Subsidiary, Files Marketing Authorization Application In The European Union For ZTlido™ - PR Newswire","headline":"Scilex Pharmaceuticals, Sorrento Therapeutics' Subsidiary, Files Marketing Authorization Application In The European Uni","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxON1NKdEptQnBCTXZmX2lpTWF0YkZWclVJYmxQZUJvMVRXS2V2dnFUUVE3NDkyYXZhakpWUmNHUzZ2QVJ0eWJ3UTRsc0RqT0toRjJiY2w1OGdNMmZFSXV1WFpwQmlQWHBHamJfb0VxSkJEd2xNSVpsdHlOeEdkUFczNlRBNVN1YUlSQ2FoRVZONFQwcnlkcFpnRGFHUDFPUkpGNWxBRzhzZnVhbjFnWTVVeDZfaElyYlZXYURINU1FSGVsYkwzWW9KMklQeXVxWkR6andEdzZ3WTllanY2TXJDb09JMWkzS1E3V0o5UGdfSHRZeVh4c3hrcVNwazkySUpoZWIweEFSN3p0bEN3dzJjUl9mYWt5Tjk4MWw1ejljalA4VUt6S0VqOXgzNGlRemlWc2FJOUUwUQ?oc=5","date":"2016-08-15","type":"deal","source":"PR Newswire","summary":"Scintilla Pharmaceuticals, Inc., a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals, Inc. to Further Deepen its Pain Management Pipeline - PR Newswire","headline":"Scintilla Pharmaceuticals, Inc., a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals, Inc. to","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}